Identification of Potent ADCK3 Inhibitors through Structure-Based Virtual Screening-Reference-Cited by-同舟云学术

Identification of Potent ADCK3 Inhibitors through Structure-Based Virtual Screening

Published:2024-07-18 Issue:15 Volume:64 Page:6072-6080
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Gao Peng¹^ORCID,Tambe Mitali¹,Chen Catherine Z.¹,Huang Wenwei¹^ORCID,Tawa Gregory J.¹,Hirschhorn Tal²,Stockwell Brent R.²^ORCID,Zheng Wei¹,Shen Min³^ORCID

Affiliation:

1. Therapeutics Development Branch, Division of Preclinical Innovation, National Center for Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States

2. Department of Biological Sciences, Department of Chemistry and Department of Pathology and Cell Biology, Columbia University, 550 West 120th Street MC 4846, 1208 Northwest Corner Building, New York, New York 10027, United States

3. Early Translation Branch, Division of Preclinical Innovation, National Center for Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States

Funder

National Center for Advancing Translational Sciences

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.4c00530

Reference32 articles.

1. Biochemistry of Mitochondrial Coenzyme Q Biosynthesis

2. Coenzyme Q biosynthesis in health and disease

3. Cerebellar ataxia and severe muscle CoQ10deficiency in a patient with a novel mutation inADCK3

4. Barca, E.; Musumeci, O.; Peverelli, L.; Ciranni, A.; DiMauro, S.; Hirano, M.; Quinzii, C. M.; Toscano, A. Cerebellar Ataxia with CoQ10 Deficiency Due to a Novel Mutation in ADCK3 (P6. 057). AAN Enterprises: 2014.

5. Primary Coenzyme Q deficiency Due to Novel ADCK3 Variants, Studies in Fibroblasts and Review of Literature